Trials / Completed
CompletedNCT04123353
Scan-Rescan Sub-Study of MS PATHS
Reproducibility of Brain Volume and Lesion Measurements in Multiple Sclerosis: a Scan-Rescan Sub-Study of Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this sub-study is to calculate the reproducibility and other technical performance measures of various magnetic resonance imaging (MRI) image analysis algorithms in order to assess their suitability for detecting changes due to multiple sclerosis (MS) in a real-world setting in participants with MS. The secondary objective of this sub-study is to use the primary endpoint results to calibrate measurements across scanners within each MS PATHS center.
Conditions
Timeline
- Start date
- 2017-02-11
- Primary completion
- 2017-05-09
- Completion
- 2017-05-09
- First posted
- 2019-10-10
- Last updated
- 2019-10-10
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04123353. Inclusion in this directory is not an endorsement.